For instance, MiR-210-3p maintains sustained activation of NF-κB signaling by targeting TNIP1 and SOCS1, negative regulators of NF-κB signaling, leading to EMT, invasion, migration, and bone metastasis of prostate cancer cell (Ren et al., 2017b). Here, NFKB1 is linked to prostate carcinoma.